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Promoting the uptake of HIV testing among men who have sex with men 
(MSM): systematic review of effectiveness and cost-effectiveness 
 
ABSTRACT 
 
Objectives: What interventions are effective and cost-effective in increasing the 
uptake of HIV testing among men who have sex with men (MSM)? 
Design: Systematic review. 
Data sources: AEGIS, ASSIA, BL Direct, BNI, Centre for Reviews and 
Dissemination, Cochrane Database of Systematic Reviews, CINAHL, Current 
Contents Connect , EconLit, EMBASE, ERIC, HMIC, Medline, Medline In-Process, 
NRR, PsychINFO, Scopus, SIGLE, Social Policy and Practice, Web of Science, 
websites, journal hand-searching, citation chasing and expert recommendations. 
Review methods: Prospective studies of the effectiveness or cost-effectiveness of 
interventions (RCT, controlled trial, one-group or any economic analysis) were 
included if the intervention aimed to increase the uptake of HIV testing among MSM 
in a high-income (OECD) country. Quality was assessed, and data extracted, using 
standardised tools. Results were synthesized narratively. 
Results: Twelve effectiveness studies and one cost-effectiveness study were located, 
covering a range of intervention types. There is evidence that rapid testing and 
counselling in community settings (one RCT), and intensive peer counselling (one 
RCT), can increase uptake of HIV testing among MSM. There are promising results 
regarding the introduction of opt-out testing in STI clinics (two one-group studies). 
Findings regarding other interventions, including bundling HIV tests with other tests, 
peer outreach in community settings, and media campaigns, are inconclusive. 
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Conclusions: Findings indicate several promising approaches to increasing HIV 
testing among MSM. However, there is limited evidence overall, and evidence for the 
effectiveness of key intervention types (particularly peer outreach and media 
campaigns) remains lacking. 
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Promoting the uptake of HIV testing among men who have sex with men 
(MSM): systematic review of effectiveness and cost-effectiveness 
 
There are estimated to be 33,300 MSM living with HIV in the UK, of whom 8,950 are 
undiagnosed (2008 figures).[1] Strategies to prevent HIV in this population include 
public health education and community-based awareness-raising about the risks of 
HIV, and the promotion of safer sex through condom distribution, outreach work and 
other means. Increasing the uptake of voluntary counselling and testing (VCT) also 
has a potentially important role to play in reducing the incidence of HIV. Of MSM 
attending genitourinary medicine (GUM) clinics in 2008, 3.1% were found to have a 
previously undiagnosed HIV infection.[1] Promoting HIV testing has the potential to 
reduce undiagnosed infections, hence improving individual outcomes and reducing 
transmission. It may also be of value in raising awareness of HIV more broadly, and 
engaging MSM with sexual health services. 
 
Promoting HIV testing may be of particular value in reducing late diagnoses. Of new 
HIV diagnoses among MSM in 2008, 43% had CD4 cell counts below the threshold 
at which treatment should normally be commenced (<350 per mm
3
 within three 
months of diagnosis), and 20% had CD4 counts less than 200 per mm
3
.[1] Late HIV 
diagnosis is an important predictor of morbidity and mortality. Those who start 
treatment at a more advanced stage of disease respond less well to treatment, and 
remain at increased risk of death for many years following treatment initiation.[2]  
 
Rates of HIV testing among MSM vary widely between countries,[3] and between 
subgroups of MSM within the UK.[4] Rates have varied over time; survey data show 
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a steady upward trend in numbers ever tested for HIV in samples of MSM in the UK 
since 2000.[5] Testing policies also vary internationally, although there is a general 
trend towards recommending more routine testing.[6] Current UK guidelines 
recommend that HIV testing should be offered to MSM annually, and more frequently 
if symptoms indicative of seroconversion or high risk exposure are present;[7] US 
guidelines recommend annual screening for MSM who themselves or whose sex 
partners have had more than one sex partner since their most recent HIV test.[8] ‘Opt-
out’ testing policies in STI clinics are now widely implemented, having been 
recommended by WHO and UNAIDS in 2004,[9] and by UK guidelines in 2006.[10] 
Current UK guidelines also recommend opt-out testing in a much wider range of 
healthcare settings.[7]  
 
We aimed to systematically review the evidence on the effectiveness and cost-
effectiveness of interventions to increase uptake of HIV testing among MSM. The 
study presented here is part of a larger review, which also included relevant 
qualitative evidence, commissioned by NICE (the review protocol has not been 
published). The full methods and results are available at 
http://www.nice.org.uk/guidance/index.jsp?action=download&o=50931. This review 
includes only interventions which aimed to promote HIV testing, although it is clear 
that the promotion of HIV testing should form part of an integrated risk-reduction 
strategy aiming to change a range of sexual behaviours.[11-12]  
 
To our knowledge, no systematic review with this scope has previously been 
conducted. Two high-quality systematic reviews whose scope partially overlaps with 
that of the present review were located by our searches. One of these focused on mass 
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media interventions to promote HIV testing, but included all populations, not only 
MSM.[13] The other included HIV health promotion interventions for MSM in 
general, but did not have a primary focus on HIV testing, and did not include a 
separate synthesis of evidence relating to interventions promoting HIV testing.[14] 
 
METHODS 
 
Identification of studies 
 
We searched the following databases from 1996 to December 2009: AEGIS 
(AIDSLine and International AIDS Society abstract archives); ASSIA; BL Direct; 
British Nursing Index; Centre for Reviews and Dissemination databases (including 
DARE and NHS EED); Cochrane Library (including the Health Technology 
Assessment database and CENTRAL); CINAHL; Current Contents Connect ; 
EconLit; EMBASE; ERIC (Education Resources Information Centre); HMIC; 
Medline; Medline In-Process; National Research Register; PsycINFO; Scopus; 
SIGLE; Social Policy and Practice; Web of Science (including Social Science 
Citation Index, Science Citation Index, and Conference Proceedings Citation Index). 
 
Where possible, searches were limited to studies of humans published in English. The 
Medline search strategy is presented in web-only supplement 1. Full search strategies 
are available in the complete review report.[15] Searching was conducted 
simultaneously for this review and the review of qualitative evidence (the strategy 
was designed to locate both types of evidence, and all references were screened for 
inclusion in both reviews).  
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In addition, we hand-searched nine key journals from January 2005 to December 
2009; scanned the citation lists of included studies and those of systematic reviews 
which met all other criteria for inclusion; and conducted ‘forward’ citation chasing on 
included studies using ISI Web of Knowledge. Finally, a call for evidence to experts 
and stakeholders was issued; all references arising from the call were screened for 
inclusion. 
 
Inclusion criteria 
 
The inclusion criteria were as follows: 
1) Does the study include men who have sex with men (MSM), or focus on 
services aimed at MSM? 
2) Does the study relate to HIV testing?  
3) Was the study conducted in a country which is a current member of the 
OECD? 
4) Was the study published in 1996 or later? 
5) Does the study include MSM who are HIV-negative or do not know their HIV 
status, and are competent to consent to an HIV test? 
6) Does the study relate to an intervention that aims to increase the uptake of 
HIV testing? 
7) Is the study a prospective outcome evaluation (randomised or non-randomised 
controlled trial, or one-group before-and-after study), or a cost-benefit or cost-
effectiveness analysis, or any other type of economic evaluation? 
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For criterion (1), studies which either had a sample more than 50% of whom were 
MSM, or presented disaggregated outcome data on the MSM within the sample, or 
focused on services aimed at MSM, were included. Studies of the general population 
which did not present outcome data on MSM were excluded. Studies published prior 
to 1996 were excluded (criterion 4) due to the lesser relevance of data collected 
before the introduction of effective anti-retroviral treatment for HIV. 
 
For criterion (7), effectiveness studies were included if they either contained a 
comparison group receiving different interventions (randomised or non-randomised) 
and/or presented outcome data for both before and after the intervention, or both. Any 
economic evaluation was included regardless of study design. Systematic reviews 
were not included; however, systematic reviews meeting criteria (1)-(6) were retained 
and their lists of included primary studies scanned for inclusion. 
 
A random sample of 10% of abstracts was screened by two reviewers independently. 
Inter-rater reliability (Cohen’s kappa) was κ=0.627. Subsequently all abstracts were 
screened by one reviewer alone. For all references included on abstract, the full text 
was retrieved and re-screened independently by two reviewers, with disagreements 
resolved by discussion and reference to a third reviewer if necessary. 
 
Study quality 
 
Study quality was assessed using a standardised tool.[16] The full quality assessment 
tool is presented in web-only supplement 2. Both quality assessment and data 
extraction were conducted for a sample of 10% of studies (N=2) by two reviewers 
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independently; subsequently all references were quality-assessed by one reviewer and 
then checked in detail by a second reviewer. On the basis of this quality assessment, 
each study was assigned a rating: high (++), medium (+) or low (–). Quality ratings 
are presented for each study below; studies were not formally weighted by quality in 
the synthesis. 
 
Data extraction and synthesis 
 
Data were extracted from the studies using a standardised tool.[16] The list of 
variables for which data were extracted is presented in web-only supplement 2. 
Outcome data were only extracted regarding the uptake of HIV testing and the 
number of new diagnoses; data on other outcomes (e.g. condom use) were not 
extracted. Due to the heterogeneity of intervention types, quantitative meta-analysis 
was not carried out, and studies were synthesized narratively. 
 
RESULTS 
 
A total of 4,342 unique references were located by our searches (this figure includes 
studies for the qualitative review as well as those for this review). After screening, a 
total of 14 study reports on effectiveness and one on cost-effectiveness were retained 
in the review. Two of these were linked reports presenting data from the same study. 
Hence, a total of 12 effectiveness studies and one cost-effectiveness study were 
included. The flow of literature through the review is presented in Figure 1. 
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Basic characteristics of the study settings and populations are set out in Table 1. Table 
1 also shows the results of the quality assessment process (full details are given in the 
full report).[15] Table 2 sets out the interventions evaluated and the findings of the 
studies. We have divided the interventions into four categories: 
1) offering different types of test or testing protocols in outreach settings;[17-19] 
2) peer education or recruitment programmes, including intensive residential 
programmes[20] and community-based programmes;[21-23] 
3) community-based media campaigns[24-25] and web-based educational 
interventions;[26] and 
4) changes to the way in which services are delivered in STI clinics, including the 
introduction of opting-out schemes[27-28] and the implementation of guidelines 
recommending regular screening.[29] 
 
Broadly, these four categories can be grouped as service delivery interventions (1 and 
4) and community-level interventions (2 and 3). 
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Table 1. Summary of included studies: population characteristics 
Study 
reference 
Study 
type  
Quality 
score 
Population 
targeted 
Country Sampling and 
recruitment 
Sample 
size 
Baseline 
demographics 
Baseline HIV 
testing experience 
Type of test / testing protocol 
Spielberg et al. 
2005[18] 
RCT ++ MSM and 
injecting drug 
users (only 
MSM findings 
reported here) 
USA All men using 
bathhouse 
approached to 
participate 
3,140 
(partici
pated) 
561 
(agreed 
to test) 
Age: 22% <30 
Ethnicity: 80% white 
(estimated, for eligible 
population) 
6% never (of 
eligible population; 
those tested <3 
months ago were 
excluded) 
Galvan et al. 
2006[17] 
 
nRCT + Latino MSM USA Randomly 
sampled from 
men entering bars 
popular with 
Latino MSM 
394  Ethnicity: All Latino. 
Other details NR for 
eligible population 
(only for those men 
agreeing to test) 
NR 
Spielberg et al. 
2000[19] 
RCT ++ MSM, injecting 
drug users and 
women at 
heterosexual 
risk (only MSM 
findings 
reported here) 
USA From the HIV 
Network for 
Prevention Trials 
Vaccine 
Preparedness 
Study (VPS) 
Cohort 
140 NR for MSM group NR 
Peer education and recruitment 
Flowers et al. 
2002[21, 30] 
 
nRCT + MSM  Scotland All men entering 
one of 10 gay 
bars in given time 
4,774 
(total) 
Age: mean 31.7 years. 
SES: 87% social class 
I-III. 
49.3% never  
 12 
period were 
approached 
Education: 40% at least 
degree level. 
Elford et al. 
2000[22, 31] 
nRCT – MSM  England Peer educators 
recruited from 
gyms with 
predominantly 
gay clientele by 
gym managers  
5,656 
(total) 
Age: median 33 years. 
Ethnicity: 89% white. 
Employment: 88% 
employed. 
27% never, 10% <3 
months ago, 18% 
4-12 months ago, 
45% >1 year ago 
Wilton et al. 
2009[20]  
RCT ++ Black MSM USA Outreach, 
referrals from 
service users and 
gatekeepers, 
advertising 
338 Age: mean 29.6 years. 
Ethnicity: all self-
identified as Black. 
SES: 46.4% income 
<$20,000 p.a. 
Education: 29.9% 
college degree. 
Sexual orientation: 
78.1% gay / 
homosexual; 18.3% 
bisexual. 
96.1% ever, 41.4% 
<3 months ago 
Golden et al. 
2006[23] 
Economic 
analysis 
(non-
comparati
ve data) 
– MSM USA Through health 
services, 
advertising, 
outreach 
283 
(recruit
ers) + 
498 
(peers) 
Unclear Unclear 
Media and web-based campaigns 
Guy et al. 
2009[24] 
Before-
and-after 
– MSM  Australia  Participants in 
Melbourne Gay 
Community 
Periodic Survey 
4,988 
(total) 
NR for this sample 60.3% < 12 months 
ago 
 13 
 
 
McOwan et al. 
2002[25] 
Before-
and-after 
– MSM, 
particularly 
black and 
southern 
European 
England Record review 357 
(total) 
Age: 9% under 25. 
Ethnicity: 5% 'south 
European' origin; 3% 
Black origin.  
(of those seeking HIV 
test at targeted clinic) 
NR 
Chiasson et al. 
2009[26] 
Before-
and-after 
+ MSM USA Recruited through 
a banner advert 
on a gay sexual 
meeting site 
3,052 
(consen
ted); 
1,463 
(receive
d 
interve
ntion) 
Age: 22% 18-29, 36% 
30-39, 42% ≥40.  
Ethnicity: 72% White.  
Education: 51% college 
degree.  
Sexual orientation: 91% 
homosexual, 9% 
bisexual. 
6% never  
STI clinic service delivery  
Dukers-
Muijrers et al. 
2009[27] 
Before-
and-after 
– General 
population (only 
MSM findings 
reported here)  
Nether-
lands 
Record review 1,127 
(total) 
NR for MSM NR 
Heijman et al. 
2009[28] 
Before-
and-after 
+ General 
population (only 
MSM findings 
reported here) 
Nether-
lands 
Record review 8,047 
(total) 
Age: 29% ≤29, 34% 
30-39, 25% 40-49, 12% 
≥50.  
Nationality: 72% Dutch 
 
16% never 
Ryder et al. 
2005[29] 
Before-
and-after 
– MSM Australia Record review 
(random sample) 
569 Age: median 33 years NR 
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Table 2. Summary of included studies: interventions and outcomes 
Study 
reference 
Intervention and comparison Follow-up 
(measured 
from start of 
intervention 
delivery) 
HIV testing outcome HIV testing findings New 
diagnoses: 
N (% of 
completed 
tests) 
Type of test / testing protocol 
Spielberg et 
al. 2005[18] 
Four testing protocols offered in gay 
bathhouses. (1) Traditional serum testing and 
a return visit to receive results, with standard 
face-to-face counselling before testing; (2) 
rapid serum testing with same-day test results 
and single-session counselling; (3) oral fluid 
testing with standard counselling; (4) 
traditional serum testing with the choice of 
pre-test written materials or standard 
counselling. 
Immediate Acceptance of testing; 
completion of testing; 
receipt of test results 
Acceptance. (1): 15.8%; (2): 
21.2% *; (3): 22.8% *; (4): 13.6% 
Completion. (1): 12.4%; (2): 
16.2% *; (3): 17.3% *; (4): 11.2% 
Receipt. (1): 9.1%; (2): 16.0% *; 
(3): 12.5% *; (4): 8.4%  
[significance tests by comparison 
with group (1)] 
(1 and 4): 
13 (6.1%) 
(2 and 3): 2 
(0.9%) 
Galvan et 
al. 2006[17] 
 
HIV tests bundled with other tests (for other 
STIs, alcohol and drug dependence and 
depression) offered in bars. Comparison: HIV 
tests alone. 
Immediate Acceptance of testing I (bundled): 10.2% 
C (HIV alone): 8.9% 
I (bundled): 
5 (3.4%) 
C (HIV 
alone): 10 
(5.1%) 
Spielberg et 
al. 2000[19] 
Two types of HIV tests for home testing: (1) 
dried blood spot home collection, 3 cycles, 
bimonthly. (2) oral fluid home collection, 3 
cycles, bimonthly. 
20 weeks Adherence to home 
specimen collection 
schedule 
(1) 92%; (2) 99% [not tested for 
significance by study authors] 
NR 
Peer education and recruitment 
Flowers et Risk-reduction education in bars delivered by 15 months Self-reported ever I: 47.0% baseline, 47.9% at 15 NR 
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Study 
reference 
Intervention and comparison Follow-up 
(measured 
from start of 
intervention 
delivery) 
HIV testing outcome HIV testing findings New 
diagnoses: 
N (% of 
completed 
tests) 
al. 2002[21, 
30] 
 
peer educators over 9 months. Peer educators 
received 2 days of training and support 
throughout the intervention. Training involved 
communication skills, role play and message 
delivery. Comparison: no intervention. 
testing months. 
C: 55.1% baseline, 52.8% at 15 
months.  
Elford et al. 
2000[22, 
31] 
Peer educators were identified on the basis of 
social connections and communication skills. 
They received training and were asked to talk 
to at least 20 gay men over the next 5 months 
about risk reduction. Comparison: no 
intervention. 
18 months Self-reported ever 
testing 
I: 72% baseline, 78% at 18 
months.  
C: 78% baseline, 87% at 18 
months. 
NR 
Wilton et 
al. 2009[20]  
Intensive 3-day residential risk-reduction 
intervention led by trained Black MSM peers. 
The intervention was conducted in a small 
group and focused on relationships, HIV risk, 
behaviour change, racism and homophobia. 
Comparison: waiting list. 
6 months Self-reported HIV 
testing in last 3 
months 
I: 38.4% baseline, 52.0% at 3 
months, 54.8% at 6 months 
C: 44.3% baseline, 46.3% at 3 
months, 43.3% at 6 months * 
I: 4 (5.8%) 
C: 4 (6.9%) 
Golden et 
al. 2006[23] 
Peer recruitment programme. Recruiters were 
identified from service users and through 
advertisements and outreach. They received 
40 minutes of training and were offered 
US$20 for each peer recruited (peers also 
received $20 if tested). Peers were tested for 
HIV, hepatitis A, B and C, and syphilis. 
29 months Cost per newly-
identified HIV-
infected person; cost 
per newly-identified 
person who received 
test results  
Per new case: US$4929. Per new 
case who received test results: 
US$5377 
22 (5.0%) 
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Study 
reference 
Intervention and comparison Follow-up 
(measured 
from start of 
intervention 
delivery) 
HIV testing outcome HIV testing findings New 
diagnoses: 
N (% of 
completed 
tests) 
Media and web-based campaigns 
Guy et al. 
2009[24] 
Multi-component social marketing campaign, 
including display advertising, print and radio 
advertisements, and a website. Targeted 
messages were aimed at young MSM, non-
gay-community-attached MSM, and culturally 
and linguistically diverse MSM. 
2 years  Self-reported testing 
in last 12 months 
60.3% baseline, 61.4% at 1 year, 
61.9% at 2 years 
NR 
McOwan et 
al. 2002[25] 
Print media promoting testing at a specific 
venue, distributed regularly to gay venues by 
community outreach teams. 
12 weeks Number of tests 
carried out at targeted 
clinic 
N=65 over 12 weeks prior to 
intervention, N=292 over 12-week 
intervention period * 
NR 
Chiasson et 
al. 2009[26] 
Educational video (viewed online) designed to 
promote critical thinking about HIV risk 
3 months Self-reported testing 
in last 3 months 
26% baseline, 44% at 3 months * 17 (14.2%) 
STI clinic service delivery 
Dukers-
Muijrers et 
al. 2009[27] 
Opt-out HIV testing policy in STI clinic 3 years Refusal of HIV test 16% at baseline; 10% 
immediately after intervention; 
6% in years 1-2; 2.1% by end of 
year 3 * 
(2.8%) 
across study 
period: N 
NR 
Heijman et 
al. 2009[28] 
Opt-out HIV testing policy in STI clinic 11 months Uptake of HIV test 62% at baseline, 88% 
immediately after intervention, 
93% at 11 months [not tested for 
significance by study authors] 
95 (3.7%) 
baseline; 
117 (3.4%) 
after 
intervention 
Ryder et al. Implementation of guidelines in STI clinic 1 year Proportion of MSM 73% baseline, 88% at follow up  NR 
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Study 
reference 
Intervention and comparison Follow-up 
(measured 
from start of 
intervention 
delivery) 
HIV testing outcome HIV testing findings New 
diagnoses: 
N (% of 
completed 
tests) 
2005[29] recommending at least annual screening of 
MSM for HIV and other STIs 
(approx.) attendees testing for 
HIV 
[not tested for significance by 
study authors] 
*Significant at p=0.05 according to study authors’ analyses
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Type of test and testing protocol 
 
One study from the USA, published in 2006, compared the uptake of HIV tests 
included with a package of other tests (for other STIs, alcohol and drug dependence, 
and depression) offered in outreach settings (bars) with that of HIV tests alone.[17] 
This study found no significant difference in uptake between the two groups. 
However, there were some promising but non-significant trends among high-risk 
subgroups towards greater acceptance of the packaged tests compared to the HIV test 
alone. 
 
One study, also from the USA and conducted in 1999-2000, compared traditional 
serum testing and counselling with rapid serum testing and oral fluid testing offered in 
a gay bathhouse.[18] This study found that both rapid serum testing and oral fluid 
testing were significantly more likely to be accepted than traditional testing. This 
study provides evidence that rapid testing modalities can increase uptake in an 
outreach setting compared to traditional testing. 
 
A further US study, conducted in 1996-97, compared oral fluid and blood spot home 
testing kits, finding high levels of adherence to both types of test.[19] 
 
Peer education and recruitment 
 
Two studies from the UK, both from the late 1990s (1996-99), used non-randomised 
designs to investigate the effectiveness of peer-led community-based risk-reduction 
campaigns.[21-22] Both of these studies found such campaigns not to be effective in 
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increasing HIV testing among a community sample of MSM. However, there are 
limitations in the design and reporting of both these studies (see Discussion), so they 
arguably do not provide conclusive evidence for the ineffectiveness of peer-led 
strategies. 
 
One RCT conducted in 2005-07 evaluated an intensive weekend residential 
programme for Black MSM in the USA led by trained MSM peers.[20] This study 
found a small but significant improvement in HIV testing rates among participants at 
six-month follow-up.  
 
One economic analysis, conducted in 2002-05, looked at a peer recruitment 
programme to increase rates of HIV testing, finding a cost per new case of HIV 
identified of US$4,929.[23] According to the study authors, this compares favourably 
with costs per case for other interventions, although the analysis presented falls 
considerably short of a full cost-effectiveness analysis. 
 
Media and web-based campaigns 
 
Two non-comparative studies in Australia and England investigated community-
based media campaigns to promote HIV testing among MSM, including components 
such as display advertising and websites and print media distributed to gay venues 
and organisations.[24-25] One of these studies, conducted in 2004-06, found no 
increase in the numbers of MSM in the targeted location reporting an HIV test in the 
previous year.[24] The other, conducted in 1999-2000, found a substantial increase in 
HIV tests conducted in the targeted clinic.[25] However, there are flaws in the design 
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of both these studies (see Discussion). Overall, the evidence for media campaigns 
must be regarded as inconclusive. 
 
One further non-comparative study in the USA, conducted in 2005-06, evaluated an 
educational video which was accessed through a banner advert on a gay sexual 
meeting website.[26] This study found a significant increase in HIV testing at 3-
month follow-up (and a substantial number of new diagnoses were made as a result). 
This finding is promising, although since the study is non-comparative, it does not 
permit strong conclusions to be drawn. 
 
STI clinic service delivery  
 
Two studies from the mid-2000s (2003-07), both non-comparative, investigated the 
introduction of ‘opt-out’ policies in STI clinics in the Netherlands, such that all clients 
attending the clinic received an HIV test unless they requested not to have one.[27-
28] Both these studies found substantial increases in HIV tests among MSM after the 
introduction of the opt-out policy. A finding of concern in both these studies was that 
certain groups, particularly older MSM and MSM with potentially STI-related 
symptoms, were more likely to opt out of testing after the introduction of the policy. 
 
One study from 2000-02, also non-comparative, found that the implementation of 
guidelines promoting regular HIV testing in an STI clinic resulted in an increase in 
the proportion of MSM being tested, although it is unclear if the increase reached 
significance.[29] 
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DISCUSSION 
 
This review indicates that several promising strategies are available to increase the 
uptake of HIV testing among MSM. Opt-out policies in STI clinics can increase 
testing rates, although there remain concerns about high rates of refusal among certain 
high-risk subgroups (as well as about those MSM who do not attend STI clinics). 
Offering rapid testing in outreach settings can also increase the uptake of testing 
relative to traditional testing methods. 
 
However, there is limited evidence for the effectiveness of community-level 
strategies. One study shows that a holistic group intervention, led by trained peers, 
can increase testing among a minority ethnic, socio-economically disadvantaged 
group of MSM. While this is a promising result, such interventions are resource-
intensive and may be challenging to implement. Nonetheless, further research on such 
strategies would be valuable. There are also promising findings, warranting further 
research, regarding a Web-based intervention. 
 
Evidence regarding media campaigns and peer-led outreach strategies is inconclusive. 
Methodologically, evaluations of existing programmes would benefit from measuring 
individual-level outcomes among men exposed to the intervention, as well as 
population-level outcomes, and from indexing outcome measures to the timeframe of 
the intervention (i.e. recent testing rather than lifetime testing). With regard to 
intervention content, more intensive programmes, sustained over longer timeframes 
and reaching a larger proportion of the population, are likely to have more impact, as 
studies of media campaigns in other fields have found.[32] Using formative research, 
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or the published qualitative literature, could also be of value in targeting the content 
of such interventions.  
 
Several limitations in the evidence should be noted. The findings show that, even 
where interventions succeeded in increasing uptake, numbers of new diagnoses were 
generally modest. Baseline rates of recent HIV testing in the targeted populations 
were often high: for example, Spielberg and colleagues’ study excluded 35% of 
potential participants because they had already had an HIV test within the last three 
months.[18] In addition, most studies recruited primarily from gay venues and/or 
MSM-oriented services or organisations, and were unlikely to include less gay-
identified MSM. These points raise the question as to whether evaluated interventions 
reach those MSM who are most at risk of having undiagnosed HIV. 
 
Other limitations relate to the methods of the primary studies, particularly those 
evaluating community-level interventions. First, several studies used non-comparative 
designs and were conducted over several years. This makes it difficult to distinguish 
the effects of the intervention from longer-term upward trends in testing behaviour. 
Second, several studies measured outcomes at a population level (i.e. different 
individuals were sampled at pre- and post-test), meaning that any measurement of 
effectiveness may be diluted by changes in the population. This is particularly an 
issue when the reach of interventions is limited: two studies found that relatively few 
of the targeted populations could recall direct contact with the intervention at post-test 
(29%[21] and 3%[22]). A third limitation relates to the measurement of outcomes: the 
use of lifetime HIV testing rather than recent testing,[21-22] or the total number of 
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HIV tests conducted by specific services,[25] may not provide an accurate picture of 
changes in testing behaviour.  
 
There are also some limitations in the review itself, primarily because of its 
intentionally restricted scope. This review did not consider evidence relating to HIV 
testing in populations other than MSM, although this evidence is potentially relevant; 
for example, there is evidence that mass media interventions are effective in the 
general population.[13] It also did not consider the considerable evidence on other 
risk-reduction strategies among MSM. This evidence would be valuable in providing 
the context needed to understand the longer-term impacts of successful interventions 
to promote HIV testing among MSM. For example, the role of testing in serosorting 
strategies, which remain prevalent among some groups of MSM and may involve 
substantial risk of infection,[33-34] suggests that the relation between the uptake of 
testing, infection rates, and health status, is complex and unpredictable. Hence, 
interventions to promote testing, in isolation, may not have a substantial impact on 
rates of infection. Such interventions are more likely to be effective as part of an 
integrated programme for reducing HIV infections and promoting access to anti-
retroviral treatment among MSM.  
 
 
Key messages: 
* Interventions to promote the uptake of HIV testing among men who have sex with 
men have the potential to reduce HIV risk and late diagnoses 
* Opt-out testing policies, and offering rapid testing, can increase the uptake of HIV 
testing among MSM 
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* Evidence concerning the effectiveness of community-level strategies, such as media 
campaigns or peer education and recruitment, is inconclusive 
* Strategies to promote testing should be seen in the broader context of a 
comprehensive approach to HIV prevention 
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Figure 1. Flow of literature through the review 
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Supplement 1. Search strategy used for the Medline database 
1. gay and (men or male$).mp 
2. Homosexuality, Male/ or homosexual$.mp 
3. exp homosexuality/ 
4. Men who have sex with men.mp 
5. same sex.mp 
6. MSM.mp 
7. (male and (sex work$ or prostitute$ or transactional sex$)).mp 
8. bisexual.mp or bisexuality/ 
9. or/1-8 
10. exp hiv/ 
11. exp hiv-1/ 
12. exp hiv-2/ 
13. Human immunodeficiency virus.mp 
14. hiv.mp 
15. or/10-14 
16. test$.mp 
17. VCT.mp 
18. voluntary counselling and testing.mp or voluntary counselling and testing.mp 
19. PIT.mp 
20. Provider initiated testing.mp 
21. client initiated testing.mp 
22. (sexual health or gum or sti and (service$ or clinic)).mp 
23. or/16-22 
24. (attend$ or non-attend$ or increas$ or promot$ or opt$ or particip$ or 
adherence or involvement or uptake or take-up or utilize or utilise or refus$ or referr$ 
or self-referr$ or barrier$ or decrease$ or interven$ or aware$ or opportunit$).mp 
25. Attitude to health/ 
26. Health service accessibility.mp 
27. Access to information/ 
28. Health education/ 
29. Health promotion/ 
30. Preventive health services/ 
31. Sexual behaviour.mp 
32. Patient acceptance of health care/ 
33. Patient compliance/ 
34. Risk reduction behavior/ or Risk reduction behaviour/ 
35. Risk-taking/ 
36. Motivation/ 
37. Stigma.mp 
38. (health$ adj3 (educat$ or aware$ or opportunit$ or attitude$ or access$ or 
inform$ or promot$ or prevent$ or behavio?r$)).ti,ab. 
39. (sex$ adj2 (behavio?r$ or educat$)).ti,ab. 
40. (risk$ adj3 (taking or factor$ or behavio?r$ or educat$ or reduc$)).ti,ab. 
41. (patient$ adj3 (satisfaction or educat$ or behavio?r$ or compliance or comply 
or complie$)).ti,ab. 
42. (barrier$ or facilitat$ or hinder$ or block$ or obstacle$ or restrict$ or restrain$ 
or obstruct$ or inhibit$ or impede$ or delay$ or constrain$ or hindrance).ti,ab. 
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43. (attitude$ or opinion$ or belief$ or perceiv$ or perception$ or aware$ or 
personal view$ or motivat$ or incentive$ or reason$).ti,ab. 
44. Or/25-43 
45. 24 OR 44 
46. 9 and 15 and 23 and 45  
47. limit 46 to (English language and humans) 
48. limit 47 yr= “1996 – Current” 
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Supplement 2: data extraction and quality assessment tools 
 
Quality assessment: effectiveness studies 
 
Questions: 
1. Is the source population or source area well described? 
2. Is the eligible population or area representative of the source population or 
area? 
3. Do the selected participants or areas represent the eligible population? 
4. How was confounding minimised? 
5. Were interventions (and comparisons) well described and appropriate?  
6. Was the allocation concealed?  
7. Were participants and/or investigators blind to exposure and comparison?  
8. Was the exposure to the intervention and comparison adequate?  
9. Was contamination acceptably low?  
10. Were other interventions similar in both groups?  
11. Were all participants accounted for at study conclusion?  
12. Did the setting reflect usual UK practice?  
13. Did the intervention or control comparison reflect usual UK practice?  
14. Were the outcome measures reliable? 
15. Were all outcome measurements complete?  
16. Were all important outcomes assessed?  
17. Were outcomes relevant?  
18. Were there similar follow-up times in exposure and comparison groups?  
19. Was follow-up time meaningful?  
20. Were exposure and comparison groups similar at baseline? If not, were these 
adjusted?  
21. Was Intention to Treat (ITT) analysis conducted?  
22. Was the study sufficiently powered to detect an intervention effect (if one 
exists)?  
23. Were the estimates of effect size given or calculable?  
24. Were the analytical methods appropriate?  
25. Was the precision of intervention effects given or calculable? Were they 
meaningful?  
26. Are the study results internally valid? (i.e. unbiased) 
27. Are the study results generalisable to the source population? (i.e. externally 
valid) 
 
Answers 1-25:  
++ The study has been designed/conducted in such a way as to minimise the risk of 
bias 
+ Either the answer to the checklist question is not clear from the way the study is 
reported, or the study may not have addressed all potential sources of bias  
- Significant sources of bias may persist 
NR The study fails to report this particular question  
NA Not applicable given the study design 
 
Answers 26-27:  
++ All or most of the checklist criteria have been fulfilled; where they have not been, 
the conclusions are very unlikely to alter 
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+ Some of the checklist criteria have been fulfilled, where they have not, or not 
adequately described, the conclusions are unlikely to alter 
- Few or no checklist criteria have been fulfilled and the conclusions are likely to alter 
 
NB. The answer to question 26 (internal validity) is the overall QA score given to 
each reference in the main text of the paper. 
 
Quality assessment: cost-effectiveness studies 
 
Questions: 
1. Is the study population appropriate for the topic being evaluated?  
2. Are the interventions appropriate for the topic being evaluated?  
3. Is the system in which the study was conducted sufficiently similar to the UK 
context?  
4. Were the perspectives clearly stated?  
5. Are all direct health effects on individuals included, and are all other effects 
included where they are material?  
6. Are all future costs and outcomes discounted appropriately?  
7. Is the value of health effects expressed in terms of quality adjusted life years 
(QALYs)?  
8. Are costs and outcomes from other sectors fully and appropriately measured 
and valued?  
9. Overall judgment (no need to continue if not applicable)  
10. Does the model structure adequately reflect the nature of the topic under 
evaluation?  
11. Is the time horizon sufficiently long to reflect all important differences in costs 
and outcomes? 
12. Are all important and relevant outcomes included?  
13. Are the estimates of baseline outcomes from the best available source?  
14. Are the estimates of relative "treatment" effects from the best available 
source?  
15. Are all important and relevant costs included?  
16. Are the estimates of resource use from the best available source?  
17. Are the unit costs of resources from the best available source?  
18. Is an appropriate incremental analysis presented or can it be calculated from 
the data?  
19. Are all important parameters whose values are uncertain subjected to 
appropriate sensitivity analysis?  
20. Is there any potential conflict of interest? 
21. Overall assessment 
 
Answers to questions 1-20: 
Yes; Partly; No; Unclear; Not Applicable 
 
Data extraction: effectiveness studies 
Author: 
Year: 
Citation: 
Aim of study: 
Study design: 
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Source population/s: 
Eligible population: 
Selected population: 
Excluded population/s: 
Setting: 
Method of allocation: 
Intervention/s description: 
Control/comparison/s description: 
Sample sizes: [total; intervention; control] 
Baseline comparisons: 
Study sufficiently powered? 
Primary outcomes: 
Secondary outcomes: 
Follow-up periods: 
Method of analysis: 
Results – primary outcomes: 
Results – secondary outcomes: 
Attrition details: 
Limitations identified by author: 
Limitations identified by review team: 
Evidence gaps and/or recommendations for future research: 
Source of funding: 
 
Data extraction: cost-effectiveness studies 
Author: 
Year: 
Citation: 
Type of economic analysis: 
Economic perspective: 
Setting: 
Data sources: 
Intervention/s description: 
Control/comparison/s description: 
Sample sizes: [total; intervention; control] 
Primary outcomes: 
Secondary outcomes: 
Time horizon: 
Discount rates: 
Modelling method: 
Results – primary analysis: 
Results – secondary analysis: 
Limitations identified by author: 
Limitations identified by review team: 
Evidence gaps and/or recommendations for future research: 
Source of funding: 
